The cases are reported of 13 children seen over a 22 month period who presented with a variety of acute neurological illnesses associated with Mycoplasma pneumoniae infection. Although presentation with a decreased level of consciousness or seizures was common, psychosis, hemiparesis, cranial nerve palsies, and Guillain-Barre syndrome were also seen. In contrast with published reports, only one child had an associated chest infection. Although some children have been left with residual disability, most have made a complete recovery. In this recent experience, M pneumoniae is a not rare cause of neurological illness in childhood and may present in unusual ways. (Arch Dis Child 1993; 69: 573-576) Neurological illness associated with Mycoplasma pneumoniae has been previously described, but its importance as an infective cause of acute neurological symptoms in childhood has been minimised in reviews of the subject.' Our recent experience suggests that
Neurological illness associated with Mycoplasma pneumoniae has been previously described, but its importance as an infective cause of acute neurological symptoms in childhood has been minimised in reviews of the subject.' Our recent experience suggests that the incidence of neurological disease associated with M pneumoniae in childhood is more common than report here 13 variety of ways. previously recognised. We patients who presented in a Patients Six boys and seven girls presented between June 1990 and May 1992. Ages ranged from 2-8 years to 15-3 years (mean age 8-3 years). All had been resident in the United Kingdom for at least six months before becoming ill. Diagnosis was confirmed either by a fourfold change in the titre of complement fixing antibodies to M pneumoniae, or by a high titre of IgM antibody to M pneumoniae. Table 1 summarises the clinical details of the patients.
CLINICAL FEATURES

ALTERED CONSCIOUSNESS
An encephalitic or meningoencephalitic presentation was common, occurring in 10 patients; the degree of altered consciousness varied widely. Four children had a Glasgow coma scale score of 14 on admission; however, five had a score of seven or less. Only two of GUILLAIN-BARRE SYNDROME Two children had postinfectious demyelinating polyneuropathy. One presented with gradual onset areflexic quadriparesis after a mild throat infection, whereas the other presented a more complicated picture, developing a meningoencephalitis first before proceeding to develop areflexia and weakness. In these two children the diagnosis was supported by the electrophysiological findings.
FOCAL NEUROLOGY Three patients had focal neurological signs as part of their illness. In patient 1, the onset of left facial weakness and left hemiparesis was abrupt and recovery slow. Brain imaging was normal. In patient 5, recovery was characterised by a marked extrapyramidal syndrome with a festinant gait. Patient 12 presented with tremor and unsteadiness on the right side.
CHEST SYMPTOMS In 10 patients there was no antecedent respiratory illness either in clinical or radiological terms. In the remaining three, in only one was there definite evidence of lower respiratory tract illness. The remaining two patients developed mild respiratory tract symptoms before the onset of their neurological illness. Table 2 summaries laboratory details of the patients.
INVESTIGATIONS
The diagnosis of M pneumoniae infection was based on a fourfold change in complement fixing IgG antibodies to M pneumoniae, or a positive test for IgM antibodies; in only one patient were we entirely reliant on the identification of IgM antibodies alone. In a number of patients the decrease in IgG titres reflected the timing of the samples in the illness. We did not seek to identify cold agglutinins routinely; they were present in patient 2.
Cerebrospinal fluid findings were not significant. The protein concentration was increased in only two of 12 samples (one Guillain-Barre syndrome). When white blood cell counts were increased (four of 12 samples), these were either polymorphs or lymphocytes, or a mixture of the two.
Chest radiographs were normal in four patients; in one there was left mid zone consolidation.
Computed tomography was performed in 11 patients and was reported as normal in 10. In patient 3, with the worst outcome, the initial The epidemiology of M pneumoniae infection is of interest as most of the patients reported here presented during the peak incidence of the four year epidemic cycle which mycoplasma infection runs. For example, laboratory notifications ofMpneumoniae infection to the Communicable Disease Surveillance Centre in 1990 totalled 141 0,4 whereas in 1991, the peak year of the epidemic, this figure was 3179.5
Neurological disease associated with M pneumoniae is well described6-9 and most reports describe encephalitis, meningoencephalitis, and polyradiculitis, although there are also reports of cerebellar ataxia, psychosis, transverse myelitis,'0 and myositis."1 Cerebral infarction12 and extrapyramidal features have also been described in mycoplasma related illnesses, and in one instance has been reported as part of an encephalitis lethargica-like illness.'3 Mycoplasma pneumoniae has been described as a cause of the Guillain-Barre syndrome.'4 One aspect of our patients which differs from the published reports, however, is the association with respiratory tract infection. In a review of reported patients,7 only 21% did not have an associated chest infection, whereas although the numbers are small, the reverse is true of our patients. In larger studies of acute neurological illness associated with infection, viral causes appear to play a more prominent part.'5 Our recent experience, however, suggests that Mpneumoniae may be responsible for acute neurological illness more often than previously recognised, particularly in the peak years of the epidemic cycle.
Our patients illustrate the diversity of neurological symptoms which may result from infection with M pneumoniae. Although the most common features were seizures and altered consciousness, focal neurological symptoms and bizarre behavioural symptoms were also seen. It should therefore be stressed that the diagnosis of a neurological complication of M pneumoniae infection should be considered in cases of acute encephalopathy and more unusual neurological and neuropsychiatric presentations, even if there is no antecedent respiratory illness.
The diagnosis of M pneumoniae infection rests on serological tests. This led in some of our patients to a delay in diagnosis. It has been suggested by some workers'6 that the role of mycoplasma infection is coincidental in the pathogenesis of the neurological illness.
Certainly the lack of any other means of confirming the diagnosis is a relevant objection when we consider the high prevalence of the infection in the community. Most patients described here, however, also had extensive virological and metabolic investigations, all of which were negative. With the only positive finding being the mycoplasma serology, we therefore feel confident of our diagnoses. We have taken as our diagnostic criteria a fourfold change in mycoplasma antibodies. This is because investigations were begun well into the course of the illness in many children due to delayed referral; thus we believe that we have caught the serological response decreasing in these patients. We have not relied on IgM responses in particular. Although IgM is a reliable indicator of recent infection, it is produced less often in reinfection, and thus a negative result does not exclude recent infection, especially in older patients. 17 The pathogenesis of the disorder is unknown, but there are three suggested possibilities. (1) The outcome for our patients has been largely one of substantial if not complete recovery; the rapid recovery of some of the patients once recovery has begun, as described by other workers,12 is noteworthy. A minority of our patients have been left with major neurological sequelae, but the incidence of this is higher in other reports. 24 We believe that M pneumoniae infection is not a rare cause of acute neurological illness in childhood, particularly in years of peak incidence in the four year epidemic cycle. It may present in an unusual fashion and should be considered in all acute cases of encephalopathy. The neurological illness may not be preceded by a recognised chest infection. We believe that erythromycin should be given in the acute phase of the illness, but the role of corticosteroids in this disorder remains unproved.
